Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,671

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

August 27, 2025

Study Completion Date

August 27, 2025

Conditions
Intracerebral Haemorrhage (ICH)Hypertension
Interventions
DRUG

telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg

1 pill taken orally once daily for average of 72 months

DRUG

Placebo

1 pill taken orally once daily for average of 72 months

Trial Locations (58)

333

Linkou Chang Gung Memorial Hospital, Taoyuan District

833

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

2050

Royal Prince Alfred Hospital, Sydney

2170

Liverpool Hospital, Liverpool

2444

Port Macquarie Base Hospital, Port Macquarie

3050

Royal Melbourne Hospital, Melbourne

4102

Princess Alexandra Hospital, Woolloongabba

4575

Sunshine Coast University Hospital, Birtinya

6150

Fiona Stanley Hospital, Murdoch

11000

Gampaha District General Hospital, Gampaha

11010

Ragama Teaching Hospital, Ragama

20000

Kandy Teaching Hospital, Kandy

40000

Jaffna Teaching Hospital, Jaffna

Unknown

Hospital das Clínicas de Botucatu, Botucatu

Instituto Flumignano de Medicina, Curitiba

Hospital Geral de Fortaleza, Fortaleza

Clínica Neurológica e Neurocirurgica de Joinville, Joinville

Hospital das Clínicas de Porto Alegre, Porto Alegre

Hospital Moinhos de Vento, Porto Alegre

Hospital das Clínicas de Ribeirão Preto, Ribeirão Preto

Hospital de Base São José do Rio Preto, Rio Prêto

Hospital da Bahia, Salvador

Universidade Federal de São Paulo, São Paulo

University Kebangsaan Malaysia Medical Centre, Hulu Langat

Hospital Queen Elizabeth, Kota Kinabalu

Hospital Universiti Sains Malaysia, Kubang Kerian

Sarawak General Hospital, Kuching

Hospital Seberang Jaya, Pulau Pinang

Maastricht University Medical Center, Maastricht

University College Hospital Ibadan, Ibadan

University of Ilorin, Ilorin

Jos University Teaching Hospital, Jos

Lagos University Teaching Hospital, Lagos, Lagos

Ahmadu Bello University Teaching Hospital, Zaria

National University Hospital, Singapore

Colombo North Teaching Hospital, Colombo

Kalubowila (Colombo South) Teaching Hospital, Colombo

National Hospital of Sri Lanka, Colombo

Karapitiya Teaching Hospital, Galle

Teaching Hospital Kurunegala, Kurunegala

Sri Jayewardenepura General Hospital, Nugegoda

Peradeniya Teaching Hospital, Peradeniya

Chiayi Chang Gung Memorial Hospital, Chiayi City

0112

LTD Pineo Medical Ecosystem, Tbilisi

0141

The First University Clinic of Tbilisi State Medical University, Tbilisi

0144

"LTD Urgent Neurological Clinic Neurology", Tbilisi

0179

LTD S. Khechinashvili University Hospital, Tbilisi

6419 PC

Zuyderland Medical Centre, Heerlen

6525 GC

Radboud University Medical Center, Nijmegen

EH16 4SB

Royal Infirmary Edinburgh, Edinburgh

EX2 5DW

Royal Devon & Exeter Hospital, Exeter

G51 4TF

Queen Elizabeth University Hospital, Glasgow

KY2 5AH

Victoria Hospital, Kirkcaldy

NG5 1PB

Nottingham City Hospital, Nottingham

M6 8HD

Salford Royal Hospital, Salford

S10 2JF

Royal Hallamshire Hospital, Sheffield

T4 6QG

Royal Stoke University Hospital, Stoke-on-Trent

SA6 6NL

Morriston Hospital, Swansea

All Listed Sponsors
collaborator

The University of New South Wales

OTHER

lead

The George Institute

OTHER

NCT02699645 - Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial | Biotech Hunter | Biotech Hunter